<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1400550</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Canine peripheral non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells show T helper 2-like and regulatory properties</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Protschka</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Di Placido</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Peter F.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>B&#xfc;ttner</surname>
<given-names>Mathias</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2324164"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alber</surname>
<given-names>Gottfried</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/423478"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Eschke</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2138586"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Immunology, Center for Biotechnology and Biomedicine, Faculty of Veterinary Medicine, Leipzig University</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis</institution>, <addr-line>Davis, CA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Enric M. Mateu, Autonomous University of Barcelona, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Tobias Kaeser, University of Veterinary Medicine Vienna, Austria</p>
<p>Fumihiko Katakura, Nihon University, Japan</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Maria Eschke, <email xlink:href="mailto:maria.eschke@bbz.uni-leipzig.de">maria.eschke@bbz.uni-leipzig.de</email>
</p>
</fn>
<fn fn-type="present-address" id="fn003">
<p>&#x2020;Present address: Daniela Di Placido, Department of Infectious Diseases, Istituto Superiore di Sanit&#xe0;, Rome, Italy</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1400550</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Protschka, Di Placido, Moore, B&#xfc;ttner, Alber and Eschke</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Protschka, Di Placido, Moore, B&#xfc;ttner, Alber and Eschke</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The dog is an important companion animal and also serves as model species for human diseases. Given the central role of T cells in immune responses, a basic understanding of canine conventional T cell receptor (TCR)&#x3b1;&#x3b2;<sup>+</sup> T cells, comprising CD4<sup>+</sup> single-positive (sp) T helper (Th) and CD8&#x3b1;<sup>+</sup> sp cytotoxic T cell subsets, is available. However, characterization of canine non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive (dp) and TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>&#x2212;</sup>CD8&#x3b1;<sup>&#x2212;</sup> double-negative (dn) T cells is limited. In this study, we performed a comprehensive analysis of canine dp and dn T cells in comparison with their conventional counterparts. TCR&#x3b1;&#x3b2;<sup>+</sup> T cells from peripheral blood of healthy dogs were sorted according to their CD4/CD8&#x3b1; phenotype into four populations (i.e. CD4<sup>+</sup> sp, CD8&#x3b1;<sup>+</sup> sp, dp, and dn) and selected surface markers, transcription factors and effector molecules were analyzed <italic>ex vivo</italic> and after <italic>in vitro</italic> stimulation by RT-qPCR. Novel characteristics of canine dp T cells were identified, expanding the previously characterized Th1-like phenotype to Th17-like and Th2-like properties. Overall, mRNA expression of various Th cell-associated cytokines (i.e. <italic>IFNG, IL17A, IL4, IL13</italic>) in dp T cells upon stimulation highlights their versatile immunological potential. Furthermore, we demonstrated that the CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> dn phenotype is stable during <italic>in vitro</italic> stimulation. Strikingly, dn T cells were found to express highest mRNA levels of type 2 effector cytokines (<italic>IL4, IL5, and IL13</italic>) upon stimulation. Their strong ability to produce IL-4 was confirmed at the protein level. Upon stimulation, the percentage of IL-4-producing cells was even higher in the non-conventional dn than in the conventional CD4<sup>+</sup> sp population. Constitutive transcription of <italic>IL1RL1</italic> (encoding IL-33R&#x3b1;) further supports Th2-like properties within the dn T cell population. These data point to a role of dn T cells in type 2 immunity. In addition, the high potential of dn T cells to transcribe the gene encoding the co-inhibitory receptor CTLA-4 and to produce the inhibitory cytokine IL-10 indicates putative immunosuppressive capacity of this population. In summary, this study reveals important novel aspects of canine non-conventional T cells providing the basis for further studies on their effector and/or regulatory functions to elucidate their role in health and disease.</p>
</abstract>
<kwd-group>
<kwd>dog</kwd>
<kwd>canine TCR&#x3b1;&#x3b2;<sup>+</sup> T cells</kwd>
<kwd>CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative</kwd>
<kwd>CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive</kwd>
<kwd>non-conventional T cells</kwd>
<kwd>Th2 Cells</kwd>
<kwd>Treg cells</kwd>
<kwd>peripheral blood</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="13"/>
<word-count count="6775"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Comparative Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Dogs develop a number of spontaneous immune-mediated disorders, such as autoimmune diseases (<xref ref-type="bibr" rid="B1">1</xref>) and allergies (<xref ref-type="bibr" rid="B2">2</xref>), as well as cancers (<xref ref-type="bibr" rid="B3">3</xref>). Similarities to these complex diseases in humans make the dog particularly interesting as an animal model. Given the importance of T cells in health and disease, comprehensive knowledge of canine T cells is essential to elucidate pathogenesis mechanisms, to develop new treatment strategies, and to appropriately use dogs as a model for these strategies.</p>
<p>Besides the conventional TCR&#x3b1;&#x3b2;<sup>+</sup> T cells expressing either CD4 or CD8&#x3b1; as co-receptor (i.e. CD4<sup>+</sup> single-positive (sp) and CD8&#x3b1;<sup>+</sup> sp T cells), dogs harbor non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive (dp) (<xref ref-type="bibr" rid="B4">4</xref>) and TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative (dn) T cells (<xref ref-type="bibr" rid="B5">5</xref>). Whereas conventional cytotoxic CD8 T cells mainly express the CD8&#x3b1;&#x3b2; heterodimer, canine non-conventional dp T cells predominantly express the CD8&#x3b1;&#x3b1; homodimer (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Due to their special co-receptor equipment, dp T cells possess unique immunological potential. In humans, dp T cells have been shown to be functionally relevant in cancer, infections and autoimmune diseases (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>), while in mice, they have been found to accumulate at the site of injection following subcutaneous vaccination (<xref ref-type="bibr" rid="B10">10</xref>). In dogs, increased frequencies of CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> dp T cells were reported after infection with <italic>Ehrlichia chaffeensis</italic> (<xref ref-type="bibr" rid="B11">11</xref>) and in the context of canine leishmaniasis (<xref ref-type="bibr" rid="B12">12</xref>). As shown by our group, mature extrathymic TCR&#x3b1;&#x3b2;<sup>+</sup> dp T cells comprise about 2% of circulating T cells in healthy dogs and are characterized by an activated phenotype indicated by expression of CD25 and MHC-II (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Furthermore, consistent with their effector memory phenotype, these cells have a strong IFN-&#x3b3; production capability (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Whereas dn T cells account for only 1&#x2013;3% of all T cells in the peripheral blood of mice and humans (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>), in dogs, approximately 15% of all circulating TCR&#x3b1;&#x3b2;<sup>+</sup> T cells are double-negative (<xref ref-type="bibr" rid="B5">5</xref>). This substantial population of non-conventional T cells is characterized by a remarkably high expression of CD25. CD25 is either co-expressed with FoxP3 (reminiscent of a regulatory phenotype), or without FoxP3 (reminiscent of an effector phenotype). In addition, subsets expressing IFN-&#x3b3;, GATA-3, or IL-17A suggest properties of conventional type 1 T helper (Th1), Th2, and Th17 cells, respectively (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>The recently reported increase of dn T cells after allergen desensitization, as well as the greatly increased frequency of dp T cells in dogs with adverse food reactions (<xref ref-type="bibr" rid="B16">16</xref>) indicates that canine non-conventional T cells can be involved in immune responses <italic>in vivo</italic>. However, knowledge about these cells is still limited.</p>
<p>To gain deeper insight into their phenotype(s) and functional potential, we performed a comprehensive <italic>ex vivo</italic> and <italic>in vitro</italic> analysis of canine peripheral blood dp and dn T cells in comparison with their conventional CD4<sup>+</sup> sp and CD8&#x3b1;<sup>+</sup> sp counterparts.</p>
<p>While dp T cells have versatile immunological potential, our results point to a stable dn phenotype and highlight a remarkable Th2-like potential of dn T cells. Furthermore, their high ability to express inhibitory molecules indicates putative immunosuppressive capacity of canine dn T cells.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Dogs, blood samples</title>
<p>Peripheral blood was taken by venipuncture of the <italic>vena cephalica antebrachii</italic> into heparinized collection tubes (BD Vacutainer<sup>&#xae;</sup>, 10&#xa0;ml, Li-Heparin 17 IU/ml Becton Dickinson, Heidelberg, Germany) from healthy experimental Beagle dogs (7 female, 4 male, age: 4-10 years) of the Faculty of Veterinary Medicine (Leipzig University, Leipzig, Germany). The number of dogs used for individual analyses is indicated in the figure legends. All dogs received routine vaccinations against canine distemper, rabies, canine infectious hepatitis, parvovirus infection, parainfluenza, and leptospirosis. The study was authorized by the Saxony State Office (<italic>Landesdirektion Sachsen</italic>) in Leipzig, Germany (approval numbers: DD24.1-5131/444/30; DD24.1-5131/468/16).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Isolation of canine peripheral blood mononuclear cells</title>
<p>PBMC were isolated by density gradient centrifugation. Briefly, blood was diluted with phosphate buffered saline (PBS) at a ratio of 1:1, layered above Biocoll Separating Solution (density 1077 g/l, Biochrom AG, Berlin, Germafny) and centrifuged at 500g for 30&#xa0;min at room temperature (minimal acceleration and braking). PBMC at the interphase were harvested into PBS and centrifuged at 500g for 10&#xa0;min at RT. After another washing step with PBS, remaining erythrocytes were lysed by incubation in 150 mM NH<sub>4</sub>Cl, 8 mM KHCO<sub>3</sub>, 2 mM EDTA (pH 7.0) for 5&#xa0;min at RT. The reaction was stopped by addition of PBS containing 3% fetal bovine serum (FBS, Thermo Fisher Scientific, Carlsbad, USA; and PAN-Biotech, Aidenbach, Germany). After washing with PBS, PBMC were counted in Trypan blue (Sigma-Aldrich, Taufkirchen, Germany) using a hemocytometer (Laboroptik, Lancing, UK).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Fluorescence-activated cell sorting of conventional and non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations</title>
<p>All incubation steps performed to stain cells for fluorescence-activated cell sorting were performed for 15-20&#xa0;min on ice in the dark. First, PBMC were incubated with the fixable viability dye eFluor 780 (Thermo Fisher Scientific, Carlsbad, USA) according to the manufacturer&#x2019;s protocol to discriminate viable from dead cells. The subsequent staining steps were preceded by washing with PBS, 3% FCS. To block binding of Fc receptors, cells were preincubated for 5&#xa0;min with a mixture of heat-inactivated normal serum derived from dog and rat (each 15% in PBS) before addition of the anti-canine TCR&#x3b1;&#x3b2; (clone CA15.8G7) hybridoma supernatant (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) and further incubation. In the next incubation step, a PerCP/Cy5.5-conjugated goat-anti-mouse IgG secondary antibody (Biolegend, San Diego, USA) was used for detection of TCR&#x3b1;&#x3b2;. Finally, PBMC were incubated with FITC-conjugated anti-canine CD4 (clone YKIX302.9) and APC-conjugated CD8&#x3b1; (clone YCATE55.9) antibodies (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Stained cells were applied over a 30 &#xb5;m filter (Sysmex, Norderstedt, Germany) and immediately sorted using a BD FACSAria&#x2122; III Cell Sorter (Becton Dickinson, Heidelberg, Germany). The sorting strategy is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>. After exclusion of dead cells and doublets, TCR&#x3b1;&#x3b2;<sup>+</sup> T cells from the lymphocyte gate were selected and CD4<sup>+</sup> single-positive (sp), CD8&#x3b1;<sup>+</sup> sp, CD4<sup>bright</sup>CD8&#x3b1;<sup>bright</sup> double-positive (dp), and CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative (dn) T cell subpopulations were sorted with a purity &gt;99% (Re-analysis using the FlowJo&#x2122;10 software (Treestar Inc., Ashland, OR, USA).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Primary antibodies used for fluorescence-activated cell sorting and flow cytometry analysis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Antigen</th>
<th valign="top" align="left">Clone</th>
<th valign="top" align="left">Target species</th>
<th valign="top" align="left">Isotype</th>
<th valign="top" align="left">Source</th>
<th valign="top" align="left">Conjugate</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TCR&#x3b1;&#x3b2;</td>
<td valign="top" align="left">CA15.8G7</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">mouse IgG1</td>
<td valign="top" align="left">Leukocyte Antigen Biology Laboratory, Davis, USA</td>
<td valign="top" align="left">unconjugated<break/>hybridoma supernatant</td>
</tr>
<tr>
<td valign="top" align="left">CD4</td>
<td valign="top" align="left">YKIX302.9</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">rat IgG2a</td>
<td valign="top" align="left">Thermo Fisher Scientific, Carlsbad, USA<break/>Bio-Rad, Munich, Germany</td>
<td valign="top" align="left">APC<break/>FITC</td>
</tr>
<tr>
<td valign="top" align="left">CD8&#x3b1;</td>
<td valign="top" align="left">YCATE55.9</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">rat IgG1</td>
<td valign="top" align="left">Thermo Fisher Scientific, Carlsbad, USA<break/>Bio-Rad, Munich, Germany</td>
<td valign="top" align="left">APC<break/>PerCP-eFluor 710</td>
</tr>
<tr>
<td valign="top" align="left">CD25</td>
<td valign="top" align="left">P4A10</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">mouse IgG1</td>
<td valign="top" align="left">Thermo Fisher Scientific, Carlsbad, USA</td>
<td valign="top" align="left">PE</td>
</tr>
<tr>
<td valign="top" align="left">IL-4*</td>
<td valign="top" align="left">unknown</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">mouse IgG2a</td>
<td valign="middle" align="left">Canine IL-4 Duoset ELISA detection antibody; R&amp;D Systems, Minneapolis, USA</td>
<td valign="top" align="left">Biotin</td>
</tr>
<tr>
<td valign="top" align="left">IL-10*</td>
<td valign="top" align="left">unknown</td>
<td valign="top" align="left">canine</td>
<td valign="top" align="left">mouse IgG1</td>
<td valign="middle" align="left">Canine IL-10 Duoset ELISA detection antibody; R&amp;D Systems, Minneapolis, USA</td>
<td valign="top" align="left">Biotin</td>
</tr>
<tr>
<td valign="middle" align="left">IFN-&#x3b3;</td>
<td valign="middle" align="left">CC302</td>
<td valign="middle" align="left">bovine**</td>
<td valign="middle" align="left">mouse IgG1</td>
<td valign="middle" align="left">Bio-Rad, Munich, Germany</td>
<td valign="middle" align="left">FITC</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*antibodies were used in different samples.</p>
</fn>
<fn>
<p>**cross-reactive with canine (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Gene expression analysis of purified canine peripheral conventional and non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations reveals stability of the CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative phenotype after PMA/Ionomycin stimulation. <bold>(A)</bold> Strategy for isolation of indicated CD4/CD8&#x3b1; TCR&#x3b1;&#x3b2;<sup>+</sup> subpopulations (sp: single-positive, dp: double-positive, dn: double-negative) by fluorescence-activated cell sorting and the purity (percentages) of the sorted populations are shown (representative data of one dog). <bold>(B&#x2013;G)</bold> These populations were analyzed by RT-qPCR. Expression of indicated genes <italic>ex vivo</italic> <bold>(B&#x2013;D)</bold> and after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I) <bold>(E&#x2013;G)</bold> defines the sp/dp/dn phenotype of sorted T cell subpopulations. Note that the expression of ThPOK (which is known to be associated with the gene program of CD4 T helper cells) and Runx3 (which establishes the gene program characteristic of cytotoxic CD8 T cells) is significantly higher in CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> dp T cells compared to CD8&#x3b1;<sup>+</sup> sp and CD4<sup>+</sup> T cells, respectively. <bold>(D, G)</bold>. Each dot represents one individual dog analyzed separately in independent experiments (n=4 or 5). Depending on normal distribution, data sets are presented with the mean or median (horizontal bars). Statistical differences between subpopulations are marked with lines. Additionally, in <bold>(E&#x2013;G)</bold>, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent (colored asterisks without lines). (* p &lt; 0.05; ** p &lt; 0.01; *** p &lt; 0.001; **** p &lt; 0.0001). Blue asterisks in <bold>(B)</bold> indicate significantly increased expression of CD8A in the purified CD8A sp population compared to all other populations. B2M, Beta-2-Microglobulin (reference gene for normalization).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g001.tif"/>
</fig>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Stimulation of sorted TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations and whole PBMC</title>
<p>Isolated TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations or whole PBMC were seeded at a density of 5x10<sup>5</sup> per well in IMDM medium with L-Glutamine and 25 mM HEPES (PAA Laboratories, C&#xf6;lbe, Germany) supplemented with 10% FBS (Thermo Fisher Scientific, Carlsbad, USA), 100 U/ml penicillin, and 100 &#x3bc;g/ml streptomycin (both purchased from PAA Laboratories) into 96-well round bottom cell culture plates (Techno Plastic Products AG, Trasadingen, Switzerland) and rested over night at 37&#xb0;C and 5% CO<sub>2</sub>. Then, cells were polyclonally stimulated for 5 hours at 37&#xb0;C with phorbol myristate acetate and Ionomycin (P/I) (both: 0.22 &#xb5;g/ml; Sigma-Aldrich, Taufkirchen, Germany). Medium incubation (M) served as negative control. For subsequent intracellular cytokine staining, 5 &#xb5;g/ml Brefeldin A (BrefA) (Enzo Life Sciences, New York, USA) was added to the culture.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>RNA isolation, reverse transcription and real-time PCR analysis</title>
<p>Total RNA from sorted TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations was isolated using 1&#xa0;ml RNA-Solv<sup>&#xae;</sup> Reagent (Omega Bio-tek, Norcross, USA) following manufacturer instructions. To increase the RNA yield, 2 &#xb5;l glycogen (Thermo Fisher Scientific, Vilnius, Lithuania) were added per sample. The concentration of the RNA was determined spectrophotometrically (NanoDrop, PEQLAB, Erlangen). DNA was digested with one unit DNase (Thermo Fisher Scientific)/&#xb5;g RNA for 30&#xa0;min at 37&#xb0;C. For isolation of poly(A)+ RNA, an additional ethanol precipitation was conducted with 1/8 volume RNase-free 3 M NaOAc, pH 5.7. Reverse transcription was performed using the &#x2018;High Capacity cDNA Reverse Transcription Kit&#x2019; (Applied Biosystems, Foster City, USA), containing RiboLock RNase inhibitor (Thermo Fisher Scientific), and a mixture of oligo (dT)18 (Thermo Fisher Scientific) and random hexamer primers in a PTC-200 (MJ Research, Watertown, USA). Specific primers were designed using the primer-BLAST Software (National Center for Biotechnology Information, Bethesda, USA) and synthesized by Metabion (Planegg, Germany) (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). The primers for <italic>IL2RA</italic> (CD25), <italic>IL4</italic>, and <italic>IL5</italic> were commercially available (Bio-Rad, Munich, Germany). Real-time PCR with SYBR<sup>&#xae;</sup> Green detection was performed using the iTaq Universal SYBR<sup>&#xae;</sup> Green Supermix (Bio-Rad, Munich, Germany) and a CFX Connect real time PCR detection system (Bio-Rad). Specificity was tested by melting curve analysis and an agarose gel electrophoresis (LE agarose, Biozym, Hess. Oldendorf; Germany). Only primers resulting in a single peak in melting curve analysis and a single band with the expected fragment size in gel electrophoresis were used. RT-qPCR efficiencies were calculated with the CFX Maestro Software version 2.2 (Bio-Rad) from standard curves generated by serial dilutions of appropriate cDNA samples (2-fold dilutions, 8 point-curve, conducted in duplicates). The efficiency of all reactions ranged between 90 and 110%. Beta-2-microglobulin (<italic>B2M</italic>) and succinate dehydrogenase subunit A (<italic>SDHA</italic>), were used as reference genes of different functional classes with stability verified using the CFX Maestro software based on the GeNorm algorithm (<xref ref-type="bibr" rid="B18">18</xref>) (<xref ref-type="supplementary-material" rid="ST1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). The same amount of cDNA was used for analysis of expression of the respective reference gene and target genes from the same sample. Relative quantification of the transcripts was done by the 2<sup>(-&#x394;Ct)</sup> method (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Results obtained with B2M as reference gene are shown in <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="fig" rid="f4">
<bold>4</bold>
</xref>, those normalized to SDHA in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">
<bold>4</bold>
</xref>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Primers used for real-time PCR.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Gene name</th>
<th valign="middle" align="left">Primer sequence</th>
<th valign="middle" align="left">GenBank ACCN*</th>
<th valign="middle" align="center">Position</th>
<th valign="middle" align="center">Exon</th>
<th valign="middle" align="left">Product length</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">B2M_for</td>
<td valign="middle" align="left">5&#xb4;-CTCATCCTCCTCGCTGCGT-3&#xb4;</td>
<td valign="middle" align="left">NM_001284479.1</td>
<td valign="middle" align="center">49-67</td>
<td valign="middle" align="center">1</td>
<td valign="middle" rowspan="2" align="right">84 bp</td>
</tr>
<tr>
<td valign="middle" align="left">B2M_rev</td>
<td valign="middle" align="left">5&#xb4;-ATTCTCTGCTGGGTGTCGTGA-3&#xb4;</td>
<td valign="middle" align="left">NM_001284479.1</td>
<td valign="middle" align="center">132-112</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" align="left">CD4_for</td>
<td valign="middle" align="left">5&#xb4;-CGGTATGCTGGTTCTGGAAT-3&#xb4;</td>
<td valign="middle" align="left">NM_001003252.1</td>
<td valign="middle" align="center">1044-1063</td>
<td valign="middle" align="center">6</td>
<td valign="middle" rowspan="2" align="right">118 bp</td>
</tr>
<tr>
<td valign="middle" align="left">CD4_rev</td>
<td valign="middle" align="left">5&#xb4;-GCACCTCACAGGTCAGATTG-3&#xb4;</td>
<td valign="middle" align="left">NM_001003252.1</td>
<td valign="middle" align="center">1161-1142</td>
<td valign="middle" align="center">7</td>
</tr>
<tr>
<td valign="middle" align="left">CD8A_for</td>
<td valign="middle" align="left">5&#xb4;-CGTCCTTCTCCTGTCACTGG-3&#xb4;</td>
<td valign="middle" align="left">NM_001002935.2</td>
<td valign="middle" align="center">630-649</td>
<td valign="middle" align="center">4</td>
<td valign="middle" rowspan="2" align="right">150 bp</td>
</tr>
<tr>
<td valign="middle" align="left">CD8A_rev</td>
<td valign="middle" align="left">5&#xb4;-GCCACACAGGATCCATCTCC-3&#xb4;</td>
<td valign="middle" align="left">NM_001002935.2</td>
<td valign="middle" align="center">779-760</td>
<td valign="middle" align="center">6</td>
</tr>
<tr>
<td valign="middle" align="left">CD8B_for</td>
<td valign="middle" align="left">5&#xb4;-CAAGAAGAGAGTGTGCCGGT-3&#xb4;</td>
<td valign="middle" align="left">XM_038691486.1</td>
<td valign="middle" align="center">542-561</td>
<td valign="middle" align="center">3</td>
<td valign="middle" rowspan="2" align="right">118 bp</td>
</tr>
<tr>
<td valign="middle" align="left">CD8B_rev</td>
<td valign="middle" align="left">5&#xb4;-CACACCCAAGGACACCAGTA-3&#xb4;</td>
<td valign="middle" align="left">XM_038691486.1</td>
<td valign="middle" align="center">659-640</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" align="left">CTLA4_for</td>
<td valign="middle" align="left">5&#xb4;-GGATCCTTGCAGCAGTCAGT-3&#xb4;</td>
<td valign="middle" align="left">NM_001003106.1</td>
<td valign="middle" align="center">553-572</td>
<td valign="middle" align="center">3</td>
<td valign="middle" rowspan="2" align="right">140 bp</td>
</tr>
<tr>
<td valign="middle" align="left">CTLA4_rev</td>
<td valign="middle" align="left">5&#xb4;-ACATTCTGGCTCAGTTGGGG-3&#xb4;</td>
<td valign="middle" align="left">NM_001003106.1</td>
<td valign="middle" align="center">692-673</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" align="left">FOXP3_for</td>
<td valign="middle" align="left">5&#xb4;-ACAGCACATTCCCAGAGTTCTT-3&#xb4;</td>
<td valign="middle" align="left">NM_001168461.1</td>
<td valign="middle" align="center">1033-1054</td>
<td valign="middle" align="center">8/9</td>
<td valign="middle" rowspan="2" align="right">130 bp</td>
</tr>
<tr>
<td valign="middle" align="left">FOXP3_rev</td>
<td valign="middle" align="left">5&#xb4;-TTGAGTGTCCGCTGCTTCTC-3&#xb4;</td>
<td valign="middle" align="left">NM_001168461.1</td>
<td valign="middle" align="center">1162-1143</td>
<td valign="middle" align="center">10</td>
</tr>
<tr>
<td valign="middle" align="left">GATA3_for</td>
<td valign="middle" align="left">5&#xb4;-GCGAACTGTCAAACCACCAC-3&#xb4;</td>
<td valign="middle" align="left">XM_038660403.1</td>
<td valign="middle" align="center">973-992</td>
<td valign="middle" align="center">5</td>
<td valign="middle" rowspan="2" align="right">147 bp</td>
</tr>
<tr>
<td valign="middle" align="left">GATA3_rev</td>
<td valign="middle" align="left">5&#xb4;-TCGGTTTCTGGTCTGGATGC-3&#xb4;</td>
<td valign="middle" align="left">XM_038660403.1</td>
<td valign="middle" align="center">1119-1100</td>
<td valign="middle" align="center">6</td>
</tr>
<tr>
<td valign="middle" align="left">IFNG_for</td>
<td valign="middle" align="left">5&#xb4;-GAAATGGAGAGAGGAGAGTGACA-3&#xb4;</td>
<td valign="middle" align="left">NM_001003174.1</td>
<td valign="middle" align="center">276-298</td>
<td valign="middle" align="center">2/3</td>
<td valign="middle" rowspan="2" align="right">239 bp</td>
</tr>
<tr>
<td valign="middle" align="left">IFNG_rev</td>
<td valign="middle" align="left">5&#xb4;-TGAGTTCATTTATCGCCTTGC-3&#xb4;</td>
<td valign="middle" align="left">NM_001003174.1</td>
<td valign="middle" align="center">514-494</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" align="left">IL10_for</td>
<td valign="middle" align="left">5&#xb4;-GCAGGTGAAGAGCGCATTTAG-3&#xb4;</td>
<td valign="middle" align="left">NM_001003077.1</td>
<td valign="middle" align="center">430-450</td>
<td valign="middle" align="center">4</td>
<td valign="middle" rowspan="2" align="right">150 bp</td>
</tr>
<tr>
<td valign="middle" align="left">IL10_rev</td>
<td valign="middle" align="left">5&#xb4;-GCCATCCTGGGTGTTTTGTTC-3&#xb4;</td>
<td valign="middle" align="left">NM_001003077.1</td>
<td valign="middle" align="center">579-559</td>
<td valign="middle" align="center">5</td>
</tr>
<tr>
<td valign="middle" align="left">IL13_for</td>
<td valign="middle" align="left">5&#xb4;-GAGCTGGTCAACATCACCCA-3&#xb4;</td>
<td valign="middle" align="left">NM_001003384.1</td>
<td valign="middle" align="center">154-173</td>
<td valign="middle" align="center">1</td>
<td valign="middle" rowspan="2" align="right">147 bp</td>
</tr>
<tr>
<td valign="middle" align="left">IL13_rev</td>
<td valign="middle" align="left">5&#xb4;-CCTCTGGGTCCTTTGGATGG-3&#xb4;</td>
<td valign="middle" align="left">NM_001003384.1</td>
<td valign="middle" align="center">300-281</td>
<td valign="middle" align="center">3</td>
</tr>
<tr>
<td valign="middle" align="left">IL17A_for</td>
<td valign="middle" align="left">5&#xb4;-AACTCCAGAAGGCCCTCAGAT-3&#xb4;</td>
<td valign="middle" align="left">NM_001165878.1</td>
<td valign="middle" align="center">185-205</td>
<td valign="middle" align="center">2</td>
<td valign="middle" rowspan="2" align="right">107 bp</td>
</tr>
<tr>
<td valign="middle" align="left">IL17A_rev</td>
<td valign="middle" align="left">5&#xb4;-CACTTCGCCTCCCAGATCAC-3&#xb4;</td>
<td valign="middle" align="left">NM_001165878.1</td>
<td valign="middle" align="center">291-272</td>
<td valign="middle" align="center">3</td>
</tr>
<tr>
<td valign="middle" align="left">IL1RL1_for</td>
<td valign="middle" align="left">5&#xb4;-AATTACAGCGTGACAGCAACC-3&#xb4;</td>
<td valign="middle" align="left">XM_038680201.1</td>
<td valign="middle" align="center">1001-1021</td>
<td valign="middle" align="center">5</td>
<td valign="middle" rowspan="2" align="right">149 bp</td>
</tr>
<tr>
<td valign="middle" align="left">IL1RL1_rev</td>
<td valign="middle" align="left">5&#xb4;-CCAAAGCAAGCAGAGCAGAG-3&#xb4;</td>
<td valign="middle" align="left">XM_038680201.1</td>
<td valign="middle" align="center">1149-1130</td>
<td valign="middle" align="center">7</td>
</tr>
<tr>
<td valign="middle" align="left">RORC_for</td>
<td valign="middle" align="left">5&#xb4;-CCACAGAGACAGCACCGAG-3&#xb4;</td>
<td valign="middle" align="left">XM_038423217.1</td>
<td valign="middle" align="center">83-101</td>
<td valign="middle" align="center">1</td>
<td valign="middle" rowspan="2" align="right">148 bp</td>
</tr>
<tr>
<td valign="middle" align="left">RORC_rev</td>
<td valign="middle" align="left">5&#xb4;-AACCCTTGCATCCCTCACAG-3&#xb4;</td>
<td valign="middle" align="left">XM_038423217.1</td>
<td valign="middle" align="center">230-211</td>
<td valign="middle" align="center">3/4</td>
</tr>
<tr>
<td valign="middle" align="left">RUNX3_for</td>
<td valign="middle" align="left">5&#xb4;-CAGGTTCAATGACCTCCGCT-3&#xb4;</td>
<td valign="middle" align="left">XM_847637.3</td>
<td valign="middle" align="center">1965-1984</td>
<td valign="middle" align="center">5</td>
<td valign="middle" rowspan="2" align="right">160 bp</td>
</tr>
<tr>
<td valign="middle" align="left">RUNX3_rev</td>
<td valign="middle" align="left">5&#xb4;-CTTCTGCCGGTGTCGTCTG-3&#xb4;</td>
<td valign="middle" align="left">XM_847637.3</td>
<td valign="middle" align="center">2124-2106</td>
<td valign="middle" align="center">6/7</td>
</tr>
<tr>
<td valign="middle" align="left">TBX21_for</td>
<td valign="middle" align="left">5&#xb4;-AGAGACCCAGTTCATTGCCG-3&#xb4;</td>
<td valign="middle" align="left">XM_038675209.1</td>
<td valign="middle" align="center">885-904</td>
<td valign="middle" align="center">4</td>
<td valign="middle" rowspan="2" align="right">133 bp</td>
</tr>
<tr>
<td valign="middle" align="left">TBX21_rev</td>
<td valign="middle" align="left">5&#xb4;-CACGCTGGTGTCAACAGATG-3&#xb4;</td>
<td valign="middle" align="left">XM_038675209.1</td>
<td valign="middle" align="center">1017-998</td>
<td valign="middle" align="center">6</td>
</tr>
<tr>
<td valign="middle" align="left">ZBTB7B_for</td>
<td valign="middle" align="left">5&#xb4;-GAGGACAGGACCGGAGCA-3&#xb4;</td>
<td valign="middle" align="left">XM_005622774.1</td>
<td valign="middle" align="center">46-63</td>
<td valign="middle" align="center">1/2</td>
<td valign="middle" rowspan="2" align="right">196 bp</td>
</tr>
<tr>
<td valign="middle" align="left">ZBTB7B_rev</td>
<td valign="middle" align="left">5&#xb4;-GCTGTTCATTGAGGCAGCTC-3&#xb4;</td>
<td valign="middle" align="left">XM_005622774.1</td>
<td valign="middle" align="center">241-222</td>
<td valign="middle" align="center">3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*ACCN, accession number.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Canine CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive T cells comprise T helper (Th) 1 and Th17 expression properties. <bold>(A&#x2013;D)</bold> Sorted TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations, as shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, were analyzed for expression of indicated genes <italic>ex vivo</italic> <bold>(A, B)</bold> or after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I) <bold>(C, D)</bold> (sp, single-positive; dp, double-positive; dn, double-negative). Each dot represents one individual dog analyzed separately in independent experiments (n=5). Depending on normal distribution, data sets are presented with the mean or median. Statistical differences between subpopulations are marked with lines. Additionally, in <bold>(C, D)</bold>, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent (colored asterisks without lines). (** p &lt; 0.01; *** p &lt; 0.001; **** p &lt; 0.0001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g002.tif"/>
</fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Canine CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive and particularly CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells have a remarkable type 2 potential. <bold>(A&#x2013;D)</bold> TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations sorted as shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref> were analyzed for expression of indicated type 2 immune response-related genes <italic>ex vivo</italic> <bold>(A, C)</bold> and/or after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I) <bold>(B, D)</bold> (sp: single-positive, dp: double-positive, dn: double-negative). Each dot represents one individual dog analyzed separately in independent experiments (n=5). Depending on normal distribution, data sets are presented with the mean or median. Statistical differences between subpopulations are marked with lines. Additionally, in <bold>(B, D)</bold>, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent using the Mann-Whitney test (colored asterisks without lines). (* p &lt; 0.05; ** p &lt; 0.01).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g003.tif"/>
</fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Constitutive expression of key regulatory markers and stimulation-induced upregulation of inhibitory effector molecules indicate immunosuppressive potential of CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells. <bold>(A&#x2013;E)</bold> TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations sorted as shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref> were analyzed for expression of indicated Treg-related genes <italic>ex vivo</italic> <bold>(A&#x2013;C)</bold> or after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I) <bold>(D, E)</bold> (sp, single-positive; dp, double-positive; dn, double-negative). Each dot represents one individual dog analyzed separately in independent experiments (n=5). Depending on normal distribution, data sets are presented with the mean or median. Statistical differences between subpopulations are marked with lines. Additionally, in <bold>(D, E)</bold>, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent (colored asterisks without lines). (* p &lt; 0.05; ** p &lt; 0.01; **** p &lt; 0.0001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g004.tif"/>
</fig>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Analysis of canine TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations by flow cytometry</title>
<p>Viability-dye and surface staining of stimulated canine PBMC were essentially performed as described in paragraph 2.3, except for using flow cytometry buffer (3% FBS, 0.1% sodium azide in PBS) instead of PBS/3% FBS. Primary antibodies used are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. For intracellular staining of IL-4, the FoxP3 staining kit (Thermo Fisher Scientific) was used according to the manufacturer&#x2019;s protocol. For intracellular detection of IL-10, alternatively, cells were fixed with 2% paraformaldehyde (Serva, Heidelberg, Germany) for 15 minutes at 4&#xb0;C and subsequently permeabilized using 0.5% saponin (w/v, Serva) in flow cytometry buffer. After permeabilization, blocking of Fc receptors was performed by incubation with a mixture of rat, mouse and dog serum (each 15% in PBS) for 10 minutes at room temperature. Cells were incubated for 30 minutes at room temperature with the monoclonal antibodies specific for the selected cytokines (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Finally, cells were incubated for 20 minutes with PE-Cy7-conjugated streptavidin to detect IL-4 and IL-10, respectively. Data were acquired with a BD LSR Fortessa (Becton Dickinson, Heidelberg, Germany). FlowJo 10.7.1 software (FlowJo, LLC, Ashland, OR, USA) was used for analysis. Gates were set using appropriate controls: unstimulated controls, and fluorescence minus one (FMO) controls, which include all specific antibodies of the staining panel, except the one of interest, which is replaced by its isotype control.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Statistical analysis</title>
<p>Statistical analysis was performed using Graph Pad Prism 10.2.0 software (San Diego, CA, USA). Depending on normal distribution determined using the Shapiro-Wilk test, data sets are presented with the mean or median. Statistical analysis was performed using One-way ANOVA with Tukey&#x2019;s post-test or Kruskal-Wallis test with Dunn&#x2019;s post-test to compare for differences between T cell subpopulations. Additionally, significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of medium (M) versus the PMA/ionomycin-stimulated (P/I) equivalent using the unpaired t test or Mann-Whitney test (two-tailed). The level of confidence for significance is shown in figure legends.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>RT-qPCR analysis of sorted canine conventional and non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations demonstrates stability of the CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative phenotype upon activation</title>
<p>For a detailed investigation, non-conventional TCR&#x3b1;&#x3b2;<sup>+</sup> CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive (dp) and CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative (dn) T cells were compared to conventional CD4<sup>+</sup> and CD8&#x3b1;<sup>+</sup> single-positive (sp) T cells. All four subpopulations were isolated with high purity (&gt;99%) from peripheral blood of healthy Beagle dogs by fluorescence-activated cell sorting (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) and gene expression was analyzed by reverse transcription-quantitative PCR (RT-qPCR). Noteworthy, a very high transcriptional activity of the dp T cell subset was observed. Despite a &gt;20x lower cell yield of the dp T cell subset compared to conventional T cell subpopulations, the resulting amount of RNA was similar in all groups (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>), which allowed comparison of gene expression between the populations.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>RNA yield from sorted T cell populations: The low cell number of dp T cells is compensated by their high transcriptional activity.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Sorted TCR&#x3b1;&#x3b2;<sup>+</sup>
<break/>T cell subpopulation</th>
<th valign="middle" align="center">CD4<sup>+</sup> sp</th>
<th valign="middle" align="center">CD8&#x3b1;<sup>+</sup> sp</th>
<th valign="middle" align="center">dp</th>
<th valign="middle" align="center">dn</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Average* cell number (x 10<sup>5</sup>)<break/>used for RNA extraction</td>
<td valign="middle" align="center">9.97 &#xb1; 2.3</td>
<td valign="middle" align="center">5.56 &#xb1; 0.99</td>
<td valign="middle" align="center">0.21 &#xb1; 0.05</td>
<td valign="middle" align="center">3.72 &#xb1; 0.66</td>
</tr>
<tr>
<td valign="middle" align="left">Average* RNA yield [ng]</td>
<td valign="middle" align="center">638 &#xb1; 109</td>
<td valign="middle" align="center">493 &#xb1; 83</td>
<td valign="middle" align="center">193 &#xb1; 43</td>
<td valign="middle" align="center">327 &#xb1; 30</td>
</tr>
<tr>
<td valign="middle" align="left">Calculated average* RNA yield per 10<sup>5</sup> cells [ng]</td>
<td valign="middle" align="center">87 &#xb1; 34</td>
<td valign="middle" align="center">84 &#xb1; 18</td>
<td valign="middle" align="center">1066 &#xb1; 254</td>
<td valign="middle" align="center">102 &#xb1; 22</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*mean &#xb1; SEM (5 individual dogs analyzed in 5 independent experiments).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The transcription of selected key markers was analyzed <italic>ex vivo</italic> (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B&#x2013;D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1B&#x2013;D</bold>
</xref>) and after stimulation with PMA/Ionomycin (P/I) (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E&#x2013;G</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1E&#x2013;G</bold>
</xref>). In general, gene expression was normalized to the expression levels of two stable reference genes (<xref ref-type="supplementary-material" rid="ST1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>) of different functional classes, <italic>B2M</italic> (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="fig" rid="f4">
<bold>4</bold>
</xref>) and <italic>SDHA</italic> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">
<bold>4</bold>
</xref>), yielding comparable results. The expression of CD4 and <italic>CD8A</italic> mRNA <italic>ex vivo</italic> confirmed the sp/dp/dn phenotype of the sorted T-cell fractions (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>). Increased <italic>IL2RA</italic> (CD25) transcription levels <italic>ex vivo</italic> support the high constitutive activation and/or the IL-2 dependence of both non-conventional T cell subpopulations (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Upregulation of <italic>IL2RA</italic> (CD25) mRNA expression following P/I incubation confirmed efficient stimulation of each T cell subpopulation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1F</bold>
</xref>).</p>
<p>In accordance with previous flow cytometric results (<xref ref-type="bibr" rid="B13">13</xref>), dp T cells differ from their CD8&#x3b1;<sup>+</sup> sp counterparts by only weak constitutive transcription of <italic>CD8B</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>), indicating preferential expression of the CD8&#x3b1;&#x3b1; homodimer. After P/I stimulation, <italic>CD8B</italic> was almost not detectable in dp T cells, whereas in CD8&#x3b1;<sup>+</sup> sp T cells a downregulation was observed (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1F</bold>
</xref>).</p>
<p>Consistent with their CD4<sup>+</sup>CD8A<sup>+</sup> phenotype (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>), canine peripheral blood dp T cells were characterized by constitutive mRNA expression of genes encoding the transcription factors ThPOK [known to be associated with the CD4 T helper cell gene program (<xref ref-type="bibr" rid="B21">21</xref>)] and Runx3 [establishing the gene program characteristic of CD8 cytotoxic T cells (<xref ref-type="bibr" rid="B22">22</xref>)] (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Albeit showing broader variation among the five dogs studied, ThPOK and Runx3 expression was significantly elevated in dp in comparison to the CD8&#x3b1;<sup>+</sup> sp and CD4<sup>+</sup> sp T cell subpopulation, respectively. Dn T cells showed a comparable transcription level of <italic>ZBTB7b</italic> (encoding ThPOK) and <italic>RUNX3</italic> like their CD4<sup>+</sup> sp counterparts (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1D</bold>
</xref>). The expected downregulation of <italic>CD4</italic> or <italic>CD8A</italic> mRNA expression in sp and dp populations upon P/I stimulation (<xref ref-type="bibr" rid="B5">5</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1E</bold>
</xref>) was accompanied by a downregulation of <italic>ZBTB7b</italic>/<italic>RUNX3</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1G</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1G</bold>
</xref>). Notably, the CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> phenotype of the double-negative T cell population was unaltered upon stimulation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1E</bold>
</xref>).</p>
<p>Overall, RT-qPCR analysis of sort-purified canine TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations <italic>ex vivo</italic> and after stimulation confirmed key features of non-conventional dp and dn T cells identified by flow cytometry in previous studies and revealed stability of the dn phenotype upon stimulation <italic>in vitro</italic>.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Canine CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive T cells show a comparable ability to transcribe <italic>IL17A</italic> as CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells and the expected high potential for <italic>IFNG</italic> expression</title>
<p>Expression of characteristic markers of T helper (Th)1 and Th17 cells was analyzed by RT-qPCR in sorted non-conventional and conventional TCR&#x3b1;&#x3b2;<sup>+</sup> T cell subpopulations. Consistent with previous flow cytometric results showing expression of the transcription factor T-bet only in a small proportion of dp T cells with a CD4<sup>bright</sup>/CD8&#x3b1;<sup>bright</sup> phenotype (<xref ref-type="bibr" rid="B7">7</xref>), mRNA levels of the corresponding gene <italic>TBX21</italic> was significantly lower in this population as compared to CD8&#x3b1;<sup>+</sup> sp T cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). Upon stimulation, high transcription of <italic>IFNG</italic> (encoding the effector cytokine IFN-&#x3b3;) was confirmed in both populations (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2C</bold>
</xref>) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Albeit to a lesser extent than in CD8&#x3b1;<sup>+</sup> sp and dp T cells, a stimulation-dependent increase in transcription of <italic>IFNG</italic> was also observed in CD4<sup>+</sup> sp and dn T cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2C</bold>
</xref>), consistent with previous flow cytometric results (<xref ref-type="bibr" rid="B5">5</xref>). Expression of <italic>RORC</italic>, which encodes the lineage-defining transcription factor of Th17 cells ROR&#x3b3;t (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>), was hardly detectable in any of the sorted populations <italic>ex vivo</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2B</bold>
</xref>) and upon stimulation (data not shown). Nevertheless, transcription of the gene encoding the Th17 effector cytokine IL-17A was highly upregulated in CD4<sup>+</sup> sp T cells and in dn T cells upon PMA/Iono stimulation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2D</bold>
</xref>). This is in line with previous flow cytometric findings (<xref ref-type="bibr" rid="B5">5</xref>). Interestingly, high stimulation-induced upregulation of <italic>IL17A</italic> mRNA expression was also found in dp T cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2D</bold>
</xref>) suggesting additional Th17 properties in this population.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Canine CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive and particularly CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells have remarkable T helper 2-like features</title>
<p>To test for a potential role of non-conventional dn and dp T cells in type 2 immune reactions, characteristic features of conventional Th2 cells, including mRNA expression of genes encoding the master transcription factor GATA-3, the key surface marker IL-33R&#x3b1; as well as the effector cytokines IL-4, IL-5 and IL-13, were analyzed. In line with previous flow cytometric results (<xref ref-type="bibr" rid="B5">5</xref>), CD4<sup>+</sup> sp T cells constitutively expressed <italic>GATA3</italic> and minimal expression was also detected in CD8&#x3b1; sp T cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). Furthermore, both, dp and dn T cells constitutively transcribed <italic>GATA3</italic> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). For dn T cells, this is consistent with previously published flow cytometric results showing an even higher percentage of GATA-3<sup>+</sup> cells in the dn than in the CD4<sup>+</sup> sp subpopulation (<xref ref-type="bibr" rid="B5">5</xref>). For dp T cells, this is the first indication of a role in type 2 immunity. Indeed, dp T cells showed a high capacity for transcription of genes encoding the Th2-associated cytokines IL-4 and IL-13 comparable to their CD4<sup>+</sup> sp counterparts (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). However, in dp T cells and their CD4<sup>+</sup> sp counterparts, stimulation-induced transcription levels of the gene encoding IL-5 were not increased similarly as in CD8&#x3b1;<sup>+</sup> sp T cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Strikingly, highest mRNA expression levels of all three type 2 effector cytokines IL-4, IL-5, and IL-13 were detected in dn T cells upon PMA/ionomycin stimulation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Constitutive transcription of <italic>IL1RL1</italic> (encoding IL33R&#x3b1;) in this population further supports the Th2-like phenotype (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;3C, D</bold>
</xref>).</p>
<p>Taken together, canine non-conventional dp and especially dn T cells show characteristics of conventional Th2 cells and their high ability to transcribe key effector cytokines points to an important involvement in type 2 immune responses.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Canine CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells constitutively express key regulatory markers and show stimulation-induced up-regulation of inhibitory molecules</title>
<p>In a previous study, we identified expression of the master transcription factor of conventional CD4<sup>+</sup> regulatory T (Treg) cells FoxP3 in a subset of dn T cells (<xref ref-type="bibr" rid="B5">5</xref>). Here, we further assessed the potential immunoregulatory phenotype of canine non-conventional dn and dp T cells. Comparable mRNA expression levels of <italic>FOXP3</italic> and the inhibitory receptor <italic>CTLA4</italic> were observed <italic>ex vivo</italic> in sorted dn, dp, and conventional CD4<sup>+</sup> sp T cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;4A, B</bold>
</xref>). Interestingly, the gene encoding the immunosuppressive cytokine IL-10 was constitutively transcribed by dn and CD4<sup>+</sup> sp but not dp T cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4C</bold>
</xref>). High up-regulation of <italic>IL10</italic> and <italic>CTLA4</italic> mRNA expression upon stimulation was detected in CD4<sup>+</sup> sp but not CD8&#x3b1;<sup>+</sup> sp and dp T cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4D, E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;4D, E</bold>
</xref>). Intriguingly, dn T cells showed highest stimulation-induced expression levels of both inhibitory molecules, which even exceeded those of conventional CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4D, E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;4D, E</bold>
</xref>). Taken together, these data point to a putative regulatory role of canine non-conventional dn T cells.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Canine CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells are potent IL-4 and IL-10 producers</title>
<p>The capacity of dp and dn T cells to produce IL-4 and IL-10 was analyzed at the protein level by flow cytometry. Analysis of IFN-&#x3b3;  by intracellular cytokine staining (ICS) served as a positive control. As expected (<xref ref-type="bibr" rid="B7">7</xref>), IFN-&#x3b3; was detected in all TCR&#x3b1;&#x3b2;<sup>+</sup> T cell populations analyzed after 5&#xa0;h of PMA/Iono stimulation, with highest frequencies in dp and CD8&#x3b1;<sup>+</sup> T cells, followed by CD4<sup>+</sup> sp and dn T cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Canine CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells are potent IL-4 producers upon PMA/Ionomycin stimulation. <bold>(A&#x2013;D)</bold> Whole PBMC of five dogs analyzed in three independent experiments were incubated for 5&#xa0;h in medium (M) or stimulated with PMA/ionomycin (P/I) in the presence of Brefeldin A and intracellular cytokine staining was performed. <bold>(A)</bold> Representative zebra plots illustrating IL-4 and IFN-&#x3b3; expression by canine CD4<sup>+</sup> single-positive (sp), CD8&#x3b1;<sup>+</sup> sp, CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive (dp) and CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative (dn) T cell subpopulations gated as in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>. Appropriate cytokine gates were set using unstimulated control (medium), and fluorescence minus one (FMO) controls. The dn population shows the highest frequency of IL-4-producing cells upon stimulation. <bold>(B)</bold> Representative zebra diagrams show that upon stimulation, IL-4 is primarily produced by dn T cells with an activated CD25<sup>+</sup> phenotype. <bold>(C)</bold> Quantification of IL-4<sup>+</sup> cells within the indicated TCR&#x3b1;&#x3b2;<sup>+</sup> subpopulations after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I). Horizontal bars indicate median values. Statistical differences between subpopulations are marked with lines. Additionally, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent (colored asterisks without lines) (* p &lt; 0.05; ** p &lt; 0.01; *** p &lt; 0.001). <bold>(D)</bold> The frequency of CD25<sup>+</sup> cells within the IL-4<sup>-</sup> and IL-4<sup>+</sup> fraction of P/I-stimulated CD4<sup>+</sup> sp and dn populations was quantified. The horizontal bars indicate mean values. (* p &lt; 0.05; **** p &lt; 0.0001). (CD8&#x3b1;<sup>+</sup> sp and dp populations were excluded from this analysis due to limiting absolute numbers of IL-4<sup>+</sup> cells).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g005.tif"/>
</fig>
<p>Specific detection of IL-4 and IL-10 by ICS upon PMA/Iono stimulation was confirmed using several controls, including unstimulated and fluorescence minus one (FMO) controls. CD8&#x3b1;<sup>+</sup> sp T cells showed almost no IL-4/IL-10 expression after stimulation (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Canine CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> double-negative T cells produce IL-10 upon stimulation <bold>(A)</bold> Whole PBMC were incubated for 5&#xa0;h in medium (M) or stimulated with PMA/ionomycin (P/I) in the presence of Brefeldin A and intracellular cytokine staining was performed. <bold>(A)</bold> Representative zebra plots illustrating IL-10 and IFN-&#x3b3; expression by canine CD4<sup>+</sup> single-positive (sp), CD8&#x3b1;<sup>+</sup> sp, CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-positive (dp) and CD4<sup>+</sup>CD8&#x3b1;<sup>+</sup> double-negative (dn) T cell subpopulations gated as in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>. Appropriate cytokine gates were set using the unstimulated control (medium). Dn T cells show the highest frequency of IL-10-producing cells. <bold>(B)</bold> IL-10 producers within dn T cells are mainly CD25<sup>+</sup>. <bold>(C)</bold> Quantification of IL-10<sup>+</sup> cells within the indicated TCR&#x3b1;&#x3b2;<sup>+</sup> subpopulations after 5&#xa0;h of medium (M) incubation or stimulation with PMA/ionomycin (P/I) (n=5). Horizontal bars indicate median values. Statistical differences between subpopulations are marked with lines. Additionally, statistical significance of stimulation-induced effects was calculated for each subpopulation by direct comparison of M versus the P/I equivalent (colored asterisks without lines) (* p &lt; 0.05; ** p &lt; 0.01). <bold>(D)</bold> The frequency of CD25<sup>+</sup> cells was quantified within the IL-10<sup>-</sup> and IL-10<sup>+</sup> fraction of P/I-stimulated CD4<sup>+</sup> sp and dn populations with significant induction of IL-10. Horizontal bars indicate mean values. (* p &lt; 0.05; ** p &lt; 0.01, **** p &lt; 0.0001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1400550-g006.tif"/>
</fig>
<p>As expected, the Th1 and Th2 effector cytokines, IFN-&#x3b3; and IL-4, are barely co-produced (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). Polyclonal activation-induced IL-4 expression was detected in CD4<sup>+</sup> sp T cells, and especially in dn T cells. Of note, the frequency of IL-4<sup>+</sup> cells was higher in the dn than in the CD4<sup>+</sup> sp population (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, C</bold>
</xref>). Furthermore, IL-4<sup>+</sup> dn and CD4<sup>+</sup> sp T cells exhibit an activated phenotype, indicated by CD25 expression (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5B, D</bold>
</xref>).</p>
<p>Production of the immunosuppressive cytokine IL-10 was significantly induced in dn T cells and CD4<sup>+</sup> sp (but not in CD8&#x3b1;<sup>+</sup> sp and dp T cells) in response to PMA/Ionomycin stimulation (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A&#x2013;C</bold>
</xref>). As expected, the majority of dn T cells producing IL-10 are CD25<sup>+</sup> reminiscent of a T regulatory phenotype (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>).</p>
<p>Taken together, ICS analysis confirmed the high ability of dn T cells to produce IL-4 and IL-10, further supporting a potential role of these non-conventional T cells in type 2 and regulatory immune responses.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Despite indications of their <italic>in vivo</italic> relevance, e.g. in the context of desensitization of dogs with food hypersensitivity (<xref ref-type="bibr" rid="B16">16</xref>), canine non-conventional dp and dn T cells have been poorly characterized. To gain deeper insight into their phenotype(s) and potential function(s), in this study, peripheral blood non-conventional dp and dn T cells were comprehensively analyzed <italic>ex vivo</italic> and <italic>in vitro</italic> upon stimulation in comparison to their conventional CD4 and CD8&#x3b1;<sup>+</sup> sp counterparts. Besides identification of novel characteristics of canine dp T cells (e.g. Th17 potential), three remarkable novel features of dn T cells were revealed, i.e. (1) the CD4<sup>-</sup>CD8&#x3b1;<sup>-</sup> dn phenotype appears to be stable during <italic>in vitro</italic> stimulation, (2) dn T cells have a high ability to express Th2-associated factors, and in addition to a putative role in type 2 immunity, (3) canine dn T cells seem to have immunosuppressive capacity indicated by strong expression of regulatory molecules.</p>
<p>A role of canine dn T cells in type 2 immunity was hypothesized based on the previous finding that a significant proportion of these cells express GATA-3 (<xref ref-type="bibr" rid="B5">5</xref>), the master transcription factor of conventional Th2 cells (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). To better assess a potential type 2 phenotype of canine dn T cells here, characteristic features of Th2 cells including the ability to transcribe the genes encoding IL-4, IL-5, and IL-13 were investigated. These effector cytokines are associated with distinct functions <italic>in vivo</italic>: IL-4 is critical for induction of IgE production, IL-5 mediates recruitment of eosinophils, and IL-13 induces goblet cell hyperplasia, mucus production, and smooth muscle contraction (<xref ref-type="bibr" rid="B27">27</xref>). In line with <italic>GATA3</italic> expression, dn T cells showed highest stimulation-induced mRNA expression of <italic>IL4</italic>, <italic>IL5</italic>, and <italic>IL13</italic>. Their strong ability to produce IL-4 was confirmed at the protein level. Noteworthy, upon stimulation, the percentage of IL-4-producing cells was even higher in the non-conventional dn compared to the conventional CD4<sup>+</sup> sp population. This supports an important role of canine GATA-3<sup>+</sup> dn T cells in type 2 immunity, like anti-parasite responses and/or allergy. A potential involvement of murine TCR&#x3b1;&#x3b2;<sup>+</sup> dn T cells in type 2 immune responses has been suggested in a single study, showing that murine splenic TCR&#x3b1;&#x3b2;<sup>+</sup> dn T cells are able to produce high amounts of IL-4 upon activation (<xref ref-type="bibr" rid="B28">28</xref>). Interestingly, TCR&#x3b1;&#x3b2;<sup>+</sup> dn T cells of healthy humans hardly secrete IL-4 and only some IL-5 upon stimulation (<xref ref-type="bibr" rid="B14">14</xref>). The distinct type 2 phenotype of canine non-conventional dn T cells identified in this study was further supported by their constitutive transcription of the gene encoding the IL-33R&#x3b1;. IL-33 is a well-known key mediator to promote Th2-associated immunity exerting its biological effects via the IL-33R (<xref ref-type="bibr" rid="B29">29</xref>). Thus, the impact of IL-33 on the effector functions of canine dn T cells will be an interesting aspect to further investigate in future experiments. Noteworthy, some features of Th2 cells, i.e. transcription of <italic>GATA3</italic> and stimulation-dependent up-regulation of IL-4 and <italic>IL13</italic> expression were also identified in non-conventional dp T cells in the present study. Similar to human allergic disease, canine allergy is characterized by increased expression of the type 2 cytokines IL-4, IL-5 and IL-13, e.g. in dogs with atopic dermatitis (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). In light of our present <italic>in vitro</italic> data it will be interesting to evaluate whether canine dn T cells are a major cellular source of type 2 cytokines also <italic>in vivo</italic> and contribute to the pathogenesis of allergic disease.</p>
<p>Besides a potential role in type 2 immunity, canine non-conventional dn T cells are likely involved in immune regulation: In accordance with expression of FoxP3 already shown previously by us (<xref ref-type="bibr" rid="B5">5</xref>), we demonstrated a high capacity of dn T cells to transcribe the co-inhibitory receptor CTLA-4 and to produce the immunosuppressive cytokine IL-10 upon stimulation here. Interestingly, the increase of peripheral blood dn T cells in dogs with adverse food reaction after specific immunotherapy could be based on an immunoregulatory role of dn T cells <italic>in vivo</italic> (<xref ref-type="bibr" rid="B16">16</xref>). However, FoxP3 expression as well as immunosuppressive effector molecules were not analyzed in this study. Pinheiro et&#xa0;al., already suspected but did not analyze a possible regulatory function of canine FoxP3<sup>+</sup> dn T cells (<xref ref-type="bibr" rid="B33">33</xref>). Noteworthy, albeit murine and human dn T cells lack FoxP3 expression (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B36">36</xref>), they were shown to control immune responses both <italic>in vitro</italic> and <italic>in vivo</italic> and thus have been termed dn regulatory T cells (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B40">40</xref>). Therefore, it can be speculated that in dogs both, FoxP3<sup>+</sup> and FoxP3<sup>-</sup> regulatory T cells exist. Their actual suppressive capacity needs to be assessed <italic>in vitro</italic> and <italic>in vivo</italic> in future experiments.</p>
<p>Noteworthy, in canine dp T cells, in contrast to their conventional CD4<sup>+</sup> sp and dn counterparts, <italic>FOXP3</italic> mRNA expression is not associated with constitutive transcription of <italic>IL10</italic>. Additionally, only weak induction of <italic>IL10</italic> transcription comparably low as in the CD8&#x3b1;<sup>+</sup> sp population and no upregulation of <italic>CTLA4</italic> mRNA expression was observed in dp T cells upon stimulation. Whereas FoxP3 is a distinct marker of murine regulatory CD4<sup>+</sup> T cells, in humans, activated non-regulatory CD4<sup>+</sup> T cells were shown to also express FoxP3 albeit transiently, and at lower levels than human regulatory CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). In future experiments, the investigation of further regulatory effector molecules and mechanisms will shed light onto the actual regulatory capacity of dp T cells.</p>
<p>The diverse immunological potential of dp T cells was further highlighted in this study showing induction of mRNA expression of various T helper cell-associated cytokines (i.e., <italic>IFNG, IL17A, IL4, IL13</italic>) upon stimulation. The increased transcriptional activity of canine dp T cells shown here represents an important prerequisite for future single-cell RNA sequencing analyses, that could shed light on their potential polyfunctionality, i.e. their ability to produce combinations of cytokines at the single-cell level. Furthermore, scRNA-seq including TCR repertoire analysis, recently established for total canine TCR&#x3b1;&#x3b2;<sup>+</sup> T cells by our group (<xref ref-type="bibr" rid="B43">43</xref>), should be applied to both, purified dp and dn T cells in future experiments as this could provide initial insights into a potential biased recognition of antigens.</p>
<p>Taken together, the data presented here reveal new insights into phenotypic features and potential functions of canine dp and dn T cells and provide the basis for future <italic>in vitro</italic> and <italic>in vivo</italic> studies to elucidate their role in host defense and immunopathological diseases of dogs.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Saxony State Office (Landesdirektion Sachsen), Leipzig, Germany (approval numbers: DD24.1-5131/444/30; DD24.1-5131/468/16). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>MP: Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. DD: Data curation, Formal analysis, Investigation, Methodology, Writing &#x2013; review &amp; editing. PM: Resources, Writing &#x2013; review &amp; editing. MB: Conceptualization, Writing &#x2013; review &amp; editing. GA: Conceptualization, Funding acquisition, Resources, Supervision, Writing &#x2013; review &amp; editing. ME: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by grants AL 371/8-3 (to GA) and ES 645/1-1 (to ME) from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). The authors further acknowledge support from the German Research Foundation (DFG) and Universit&#xe4;t Leipzig within the program of OpenAccess Publishing.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Ina Hochheim and Caroline Sch&#xf6;ller from the Institute of Pharmacology, Pharmacy and Toxicology, College of Veterinary Medicine, University of Leipzig for extensive care of the dogs and providing blood samples. Aileen Wingenfeld and Anett Grohs are thanked for their excellent technical assistance. Dr. Christiane Schnabel and Dr. Uwe M&#xfc;ller are thanked for critical reading of the manuscript. Flow cytometry was performed at the Core Unit Flow Cytometry (CUDZ) of the Faculty of Veterinary Medicine, Leipzig University.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1400550/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1400550/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Presentation_1.pptx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.presentationml.presentation"/>
<supplementary-material xlink:href="Table_1.docx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gershwin</surname> <given-names>LJ</given-names>
</name>
</person-group>. <article-title>Veterinary autoimmunity: autoimmune diseases in domestic animals</article-title>. <source>Ann N Y Acad Sci</source>. (<year>2007</year>) <volume>1109</volume>:<page-range>109&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1196/annals.1398.013</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Jensen-Jarolim</surname> <given-names>E</given-names>
</name>
<name>
<surname>Roth-Walter</surname> <given-names>F</given-names>
</name>
<name>
<surname>Marti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Janda</surname> <given-names>J</given-names>
</name>
<name>
<surname>Seida</surname> <given-names>AA</given-names>
</name>
<etal/>
</person-group>. <article-title>Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs</article-title>. <source>Allergy</source>. (<year>2018</year>) <volume>73</volume>:<page-range>1989&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/all.13464</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overgaard</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Schachtschneider</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Principe</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Schook</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Jungersen</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Of mice, dogs, pigs, and men: choosing the appropriate model for immuno-oncology research</article-title>. <source>ILAR J</source>. (<year>2018</year>) <volume>59</volume>:<page-range>247&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ilar/ily014</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buttlar</surname> <given-names>Hv</given-names>
</name>
<name>
<surname>Bismarck</surname> <given-names>D</given-names>
</name>
<name>
<surname>Alber</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Peripheral canine CD4(+)CD8(+) double-positive T cells - unique amongst others</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2015</year>) <volume>168</volume>:<page-range>169&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2015.09.005</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabiger</surname> <given-names>FV</given-names>
</name>
<name>
<surname>Rothe</surname> <given-names>K</given-names>
</name>
<name>
<surname>Buttlar</surname> <given-names>Hv</given-names>
</name>
<name>
<surname>Bismarck</surname> <given-names>D</given-names>
</name>
<name>
<surname>B&#xfc;ttner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PF</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct features of canine non-conventional CD4-CD8&#x3b1;- double-negative TCR&#x3b1;&#x3b2;+ vs. TCR&#x3b3;&#x3b4;+ T cells</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>2748</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02748</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bismarck</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sch&#xfc;tze</surname> <given-names>N</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>P</given-names>
</name>
<name>
<surname>B&#xfc;ttner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alber</surname> <given-names>G</given-names>
</name>
<name>
<surname>Buttlar</surname> <given-names>Hv</given-names>
</name>
</person-group>. <article-title>Canine CD4+CD8+ double positive T cells in peripheral blood have features of activated T cells</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2012</year>) <volume>149</volume>:<page-range>157&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2012.06.014</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothe</surname> <given-names>K</given-names>
</name>
<name>
<surname>Bismarck</surname> <given-names>D</given-names>
</name>
<name>
<surname>B&#xfc;ttner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alber</surname> <given-names>G</given-names>
</name>
<name>
<surname>Buttlar</surname> <given-names>Hv</given-names>
</name>
</person-group>. <article-title>Canine peripheral blood CD4+CD8+ double-positive Tcell subpopulations exhibit distinct Tcell phenotypes and effector functions</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2017</year>) <volume>185</volume>:<fpage>48</fpage>&#x2013;<lpage>56</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2017.01.005</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishida</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kawashima</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kanazawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kidani</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hirata</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma</article-title>. <source>Int Immunol</source>. (<year>2020</year>) <volume>32</volume>:<page-range>347&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxaa004</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overgaard</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>J-W</given-names>
</name>
<name>
<surname>Steptoe</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Wells</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>CD4+/CD8+ double-positive T cells: more than just a developmental stage</article-title>? <source>J Leukoc Biol</source>. (<year>2015</year>) <volume>97</volume>:<page-range>31&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.1RU0814-382</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overgaard</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Bridge</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Nel</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Frazer</surname> <given-names>IH</given-names>
</name>
<name>
<surname>La Gruta</surname> <given-names>NL</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4+CD8&#x3b2;+ double-positive T cells in skin-draining lymph nodes respond to inflammatory signals from the skin</article-title>. <source>J Leukoc Biol</source>. (<year>2017</year>) <volume>102</volume>:<page-range>837&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.1AB0217-065R</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGill</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ganta</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Boorgula</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Ganta</surname> <given-names>RR</given-names>
</name>
</person-group>. <article-title>Antigen-specific CD4+CD8+ Double-positive T cells are increased in the blood and spleen during ehrlichia chaffeensis infection in the canine host</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>1585</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01585</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexandre-Pires</surname> <given-names>G</given-names>
</name>
<name>
<surname>Brito</surname> <given-names>MTde</given-names>
</name>
<name>
<surname>Alguer&#xf3;</surname> <given-names>C</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>OR</given-names>
</name>
<name>
<surname>Da Fonseca</surname> <given-names>IP</given-names>
</name>
<etal/>
</person-group>. <article-title>Canine leishmaniasis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2010</year>) <volume>137</volume>:<page-range>275&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2010.06.007</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabiger</surname> <given-names>FV</given-names>
</name>
<name>
<surname>Bismarck</surname> <given-names>D</given-names>
</name>
<name>
<surname>Protschka</surname> <given-names>M</given-names>
</name>
<name>
<surname>K&#xf6;hler</surname> <given-names>G</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PF</given-names>
</name>
<name>
<surname>B&#xfc;ttner</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Canine tissue-associated CD4+CD8&#x3b1;+ double-positive T cells are an activated T cell subpopulation with heterogeneous functional potential</article-title>. <source>PloS One</source>. (<year>2019</year>) <volume>14</volume>:<elocation-id>e0213597</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0213597</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Voelkl</surname> <given-names>S</given-names>
</name>
<name>
<surname>Heymann</surname> <given-names>J</given-names>
</name>
<name>
<surname>Przybylski</surname> <given-names>GK</given-names>
</name>
<name>
<surname>Mondal</surname> <given-names>K</given-names>
</name>
<name>
<surname>Laumer</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells</article-title>. <source>Blood</source>. (<year>2005</year>) <volume>105</volume>:<page-range>2828&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2004-07-2583</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>ZX</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Young</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>DuTemple</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression</article-title>. <source>Nat Med</source>. (<year>2000</year>) <volume>6</volume>:<page-range>782&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/77513</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maina</surname> <given-names>E</given-names>
</name>
<name>
<surname>Devriendt</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Food allergen-specific sublingual immunotherapy modulates peripheral T cell responses of dogs with adverse food reactions</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2019</year>) <volume>212</volume>:<fpage>38</fpage>&#x2013;<lpage>42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2019.05.003</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedersen</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Castelruiz</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jacobsen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Aasted</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Identification of monoclonal antibodies that cross-react with cytokines from different animal species</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2002</year>) <volume>88</volume>:<page-range>111&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0165-2427(02)00139-3</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandesompele</surname> <given-names>J</given-names>
</name>
<name>
<surname>Preter</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pattyn</surname> <given-names>F</given-names>
</name>
<name>
<surname>Poppe</surname> <given-names>B</given-names>
</name>
<name>
<surname>van Roy</surname> <given-names>N</given-names>
</name>
<name>
<surname>Paepe</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title>. <source>Genome Biol</source>. (<year>2002</year>) <volume>3</volume>:<fpage>RESEARCH0034</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/gb-2002-3-7-research0034</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfaffl</surname> <given-names>MW</given-names>
</name>
</person-group>. <article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title>. <source>Nucleic Acids Res</source>. (<year>2001</year>) <volume>29</volume>:<elocation-id>e45</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source>. (<year>2001</year>) <volume>25</volume>:<page-range>402&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>X</given-names>
</name>
<name>
<surname>Park</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kappes</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>The role of ThPOK in control of CD4/CD8 lineage commitment</article-title>. <source>Annu Rev Immunol</source>. (<year>2010</year>) <volume>28</volume>:<fpage>295</fpage>&#x2013;<lpage>320</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.25.022106.141715</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>J-H</given-names>
</name>
<name>
<surname>Adoro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guinter</surname> <given-names>T</given-names>
</name>
<name>
<surname>Erman</surname> <given-names>B</given-names>
</name>
<name>
<surname>Alag</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Catalfamo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells</article-title>. <source>Nat Immunol</source>. (<year>2010</year>) <volume>11</volume>:<page-range>257&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1840</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname> <given-names>II</given-names>
</name>
<name>
<surname>McKenzie</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tadokoro</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Lepelley</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lafaille</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells</article-title>. <source>Cell</source>. (<year>2006</year>) <volume>126</volume>:<page-range>1121&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2006.07.035</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manel</surname> <given-names>N</given-names>
</name>
<name>
<surname>Unutmaz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Littman</surname> <given-names>DR</given-names>
</name>
</person-group>. <article-title>The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat</article-title>. <source>Nat Immunol</source>. (<year>2008</year>) <volume>9</volume>:<page-range>641&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1610</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Cohn</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ray</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bottomly</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ray</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene</article-title>. <source>J Biol Chem</source>. (<year>1997</year>) <volume>272</volume>:<page-range>21597&#x2013;603</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.272.34.21597</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Flavell</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells</article-title>. <source>Cell</source>. (<year>1997</year>) <volume>89</volume>:<page-range>587&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80240-8</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkelman</surname> <given-names>FD</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Hershey</surname> <given-names>GK</given-names>
</name>
<name>
<surname>Rothenberg</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Wills-Karp</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Importance of cytokines in murine allergic airway disease and human asthma</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>:<page-range>1663&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0902185</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zlotnik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Godfrey</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Suda</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4</article-title>. <source>J Immunol</source>. (<year>1992</year>) <volume>149</volume>:<page-range>1211&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.149.4.1211</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Marek</surname> <given-names>RM</given-names>
</name>
<name>
<surname>L&#xf6;hning</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>IL-33 in T cell differentiation, function, and immune homeostasis</article-title>. <source>Trends Immunol</source>. (<year>2016</year>) <volume>37</volume>:<page-range>321&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2016.03.007</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majewska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gajewska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dembele</surname> <given-names>K</given-names>
</name>
<name>
<surname>Maciejewski</surname> <given-names>H</given-names>
</name>
<name>
<surname>Prostek</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jank</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis</article-title>. <source>BMC Vet Res</source>. (<year>2016</year>) <volume>12</volume>:<fpage>174</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12917-016-0805-6</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuttall</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Knight</surname> <given-names>PA</given-names>
</name>
<name>
<surname>McAleese</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Lamb</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>PB</given-names>
</name>
</person-group>. <article-title>Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis</article-title>. <source>Clin Exp Allergy</source>. (<year>2002</year>) <volume>32</volume>:<page-range>789&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2222.2002.01356.x</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivry</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mayhew</surname> <given-names>D</given-names>
</name>
<name>
<surname>Paps</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Linder</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Peredo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rajpal</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Early activation of th2/th22 inflammatory and pruritogenic pathways in acute canine atopic dermatitis skin lesions</article-title>. <source>J Invest Dermatol</source>. (<year>2016</year>) <volume>136</volume>:<page-range>1961&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jid.2016.05.117</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinheiro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Grant</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Appleton</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Sacchini</surname> <given-names>F</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>KR</given-names>
</name>
<etal/>
</person-group>. <article-title>Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dog</article-title>. <source>Immunology</source>. (<year>2011</year>) <volume>132</volume>:<page-range>111&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2567.2010.03346.x</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voelkl</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gary</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mackensen</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Characterization of the immunoregulatory function of human TCR-&#x3b1;&#x3b2;+ CD4- CD8- double-negative T cells</article-title>. <source>Eur J Immunol</source>. (<year>2011</year>) <volume>41</volume>:<page-range>739&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201040982</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Degauque</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mikita</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>XX</given-names>
</name>
</person-group>. <article-title>New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses</article-title>. <source>Blood</source>. (<year>2007</year>) <volume>109</volume>:<page-range>4071&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2006-10-050625</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hillhouse</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Lesage</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells</article-title>. <source>J Autoimmun</source>. (<year>2013</year>) <volume>40</volume>:<fpage>58</fpage>&#x2013;<lpage>65</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaut.2012.07.010</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma</article-title>. <source>Nat Commun</source>. (<year>2019</year>) <volume>10</volume>:<fpage>4246</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-12243-0</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis</article-title>. <source>Nat Commun</source>. (<year>2021</year>) <volume>12</volume>:<fpage>650</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-021-20941-x</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haug</surname> <given-names>T</given-names>
</name>
<name>
<surname>Aigner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Peuser</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Strobl</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Hildner</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mougiakakos</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Human double-negative regulatory T-cells induce a metabolic and functional switch in effector T-cells by suppressing mTOR activity</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>883</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00883</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>ZX</given-names>
</name>
<name>
<surname>Young</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>CD3+CD4-CD8- alphabeta-TCR+ T cell as immune regulatory cell</article-title>. <source>J Mol Med (Berl)</source>. (<year>2001</year>) <volume>79</volume>:<page-range>419&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s001090100238</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allan</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Crome</surname> <given-names>SQ</given-names>
</name>
<name>
<surname>Crellin</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Passerini</surname> <given-names>L</given-names>
</name>
<name>
<surname>Steiner</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Bacchetta</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production</article-title>. <source>Int Immunol</source>. (<year>2007</year>) <volume>19</volume>:<page-range>345&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxm014</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ioan-Facsinay</surname> <given-names>A</given-names>
</name>
<name>
<surname>van der Voort</surname> <given-names>EI</given-names>
</name>
<name>
<surname>Huizinga</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Toes</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells</article-title>. <source>Eur J Immunol</source>. (<year>2007</year>) <volume>37</volume>:<page-range>129&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200636435</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eschke</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PF</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Alber</surname> <given-names>G</given-names>
</name>
<name>
<surname>Keller</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Canine peripheral blood TCR&#x3b1;&#x3b2; T cell atlas: Identification of diverse subsets including CD8A+ MAIT-like cells by combined single-cell transcriptome and V(D)J repertoire analysis</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1123366</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1123366</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>